Skip to content

Homoeopathic management of menopause in women of age group 45 to 55 years

Evaluating the Role of Boger Boenninghausen?s Characteristics Repertory in the Management of Menopause in the Age Group 45-55 Years - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/094393
Enrollment
50
Registered
2025-09-08
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N951- Menopausal and female climactericstates

Interventions

Intervention1: Individualized Homoeopathic Medicine: Dose centesimal scale Frequency TDS ROUTE ORAL DURATION 6 MONTHS Control Intervention1: Nil: Not Applicable as single arm study

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: FSH level more than 40 mIU per ml Patient presenting with Vasomotor symptoms like hot flush and night sweats Psychological symptoms like mood swings poor memory Urogenital symptoms like vaginal dryness and urine troubles

Exclusion criteria

Exclusion criteria: Patient taking Hormone Replacement Therapy

Design outcomes

Primary

MeasureTime frame
Reduction in Menopausal complaintsTimepoint: Baseline fortnightly till end of 6 months

Secondary

MeasureTime frame
To improve the quality of life of women in menopausal phase by giving homoeopathy medicinesTimepoint: 6 months

Countries

India

Contacts

Public ContactDr Manish Arya

PG Scholar Department of Repertory Dr D Y Patil Homoeopathic Medical College and Research Centre

khyati.pundiri8431@gmail.com9680038050

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026